Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Chernajovsky

Showing results (41-50 of 81) with videos related to

Pageof 9
Sort By:
Clinical and Diagnostic Laboratory Immunology|September 1, 1996
Selective gamma-chain T-cell receptor gene rearrangements in a patient with Omenn's syndrome: absence of V-II subgroup (V gamma 9) transcriptsG Mathioudakis, R A Good, Y Chernajovsky, et al.
Scandinavian Journal of Immunology|July 1, 1993
Preferential rearrangements of the V gamma I subgroup of the gamma-chain of the T-cell antigen receptor to J gamma 2C gamma 2 gene segments in peripheral blood lymphocyte transcripts from normal donorsG Mathioudakis, P F Chen, Y D Li, et al.
Annals of the New York Academy of Sciences|January 1, 1983
Production of human interferon in E. coli under lac and tryplac promoter controlY Chernajovsky, Y Mory, B Vaks, et al.
Cancer Research|December 1, 1991
Predominance of the metastatic phenotype in somatic cell hybrids of the K-1735 murine melanomaA H Staroselsky, S Pathak, Y Chernajovsky, et al.
British Journal of Cancer|February 1, 1993
2'-deoxy-5-azacytidine increases binding of cisplatin to DNA by a mechanism independent of DNA hypomethylationJ A Ellerhorst, P Frost, J L Abbruzzese, et al.
European Cytokine Network|November 27, 1998
Minimal tumor necrosis factor receptor binding protein: optimum biological activity of a truncated p55 soluble tumor necrosis factor receptor-IgG fusion proteinA E Corcoran, B J Scallon, H Trinh, et al.
International Journal of Cancer|April 22, 1992
The use of molecular genetic markers to demonstrate the effect of organ environment on clonal dominance in a human renal-cell carcinoma grown in nude miceA N Staroselsky, R Radinsky, I J Fidler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 20, 1998
Cytokine gene therapy in experimental allergic encephalomyelitis by injection of plasmid DNA-cationic liposome complex into the central nervous systemJ L Croxford, K Triantaphyllopoulos, O L Podhajcer, et al.
Gene Therapy|February 27, 2001
A novel doxycycline inducible autoregulatory plasmid which displays "on"/"off" regulation suited to gene therapy applicationsD J Gould, M Berenstein, H Dreja, et al.
DNA (Mary Ann Liebert, Inc.)|August 1, 1984
Efficient constitutive production of human fibroblast interferon by hamster cells transformed with the IFN-beta 1 gene fused to an SV40 early promoterY Chernajovsky, Y Mory, L Chen, et al.
Pageof 9

Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Clinical and Diagnostic Laboratory Immunology|September 1, 1996
Selective gamma-chain T-cell receptor gene rearrangements in a patient with Omenn's syndrome: absence of V-II subgroup (V gamma 9) transcriptsG Mathioudakis, R A Good, Y Chernajovsky, et al.
Scandinavian Journal of Immunology|July 1, 1993
Preferential rearrangements of the V gamma I subgroup of the gamma-chain of the T-cell antigen receptor to J gamma 2C gamma 2 gene segments in peripheral blood lymphocyte transcripts from normal donorsG Mathioudakis, P F Chen, Y D Li, et al.
Annals of the New York Academy of Sciences|January 1, 1983
Production of human interferon in E. coli under lac and tryplac promoter controlY Chernajovsky, Y Mory, B Vaks, et al.
Cancer Research|December 1, 1991
Predominance of the metastatic phenotype in somatic cell hybrids of the K-1735 murine melanomaA H Staroselsky, S Pathak, Y Chernajovsky, et al.
British Journal of Cancer|February 1, 1993
2'-deoxy-5-azacytidine increases binding of cisplatin to DNA by a mechanism independent of DNA hypomethylationJ A Ellerhorst, P Frost, J L Abbruzzese, et al.
European Cytokine Network|November 27, 1998
Minimal tumor necrosis factor receptor binding protein: optimum biological activity of a truncated p55 soluble tumor necrosis factor receptor-IgG fusion proteinA E Corcoran, B J Scallon, H Trinh, et al.
International Journal of Cancer|April 22, 1992
The use of molecular genetic markers to demonstrate the effect of organ environment on clonal dominance in a human renal-cell carcinoma grown in nude miceA N Staroselsky, R Radinsky, I J Fidler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 20, 1998
Cytokine gene therapy in experimental allergic encephalomyelitis by injection of plasmid DNA-cationic liposome complex into the central nervous systemJ L Croxford, K Triantaphyllopoulos, O L Podhajcer, et al.
Gene Therapy|February 27, 2001
A novel doxycycline inducible autoregulatory plasmid which displays "on"/"off" regulation suited to gene therapy applicationsD J Gould, M Berenstein, H Dreja, et al.
DNA (Mary Ann Liebert, Inc.)|August 1, 1984
Efficient constitutive production of human fibroblast interferon by hamster cells transformed with the IFN-beta 1 gene fused to an SV40 early promoterY Chernajovsky, Y Mory, L Chen, et al.
Pageof 9